Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 5:22 AM ET

Healthcare Providers and Services

Company Overview of Mayo Foundation For Medical Education And Research

Company Overview

Mayo Foundation is a not-for-profit foundation with $116 million assets under management. The foundation focuses on medical research and education. It operates through its subsidiaries including Mayo Clinic Rochester, Mayo Clinic Jacksonville, Mayo Clinic Jacksonville, Mayo Foundation For Medical Education and Research, Mayo Group Practices, and Mayo Health System. Mayo Foundation is based in Rochester, Minnesota.

200 First Street SW

Rochester, MN 55905

United States

Founded in 1984





Key Executives for Mayo Foundation For Medical Education And Research

Chief Financial Officer
Assistant Secretary
Assistant Treasurer
Age: 60
Compensation as of Fiscal Year 2015.

Mayo Foundation For Medical Education And Research Key Developments

TapImmune, Inc. Signs License Agreement with Mayo Foundation

TapImmune Inc. has entered into a license agreement with Mayo Foundation for Medical Education and Research to commercialize a proprietary folate receptor alpha vaccine technology for all cancer indications. Both the companies are based in the US. Under the agreement, Mayo Foundation granted TapImmune a license on a worldwide basis to make, sell and use products for therapeutic use against breast, ovarian, lung and other cancers that express folate receptor alpha. This license is an exclusive license for products that are based on the intellectual property and non-exclusive for products that are based on Mayo Foundation know-how and materials. The intellectual property that is being licensed includes (i) U.S. patent application numbers 12/303,054 and 13/202,236, (ii) U.S. patent number 8,486,412 and 8,858,952 and provisionals, (iii) divisional including 13/917,410 and (iv) continuations including 14/484,057. The Mayo Foundation granted this license in exchange for an initial upfront payment of $0.35 which was made on July 21, 2015. In addition to the initial upfront payment, TapImmune is to pay additional upfront payments, an annual license maintenance fee, milestone fees and royalty fees.

Mayo Clinic Center for Regenerative Medicine Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014 09:00 AM

Mayo Clinic Center for Regenerative Medicine Presents at Alliance for Regenerative Medicine 2nd Annual Regen Med Investor Day, Mar-26-2014 09:00 AM. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022, United States. Speakers: Andre Terzic, M.D., Ph.D., Michael S. & Mary Sue Shannon Director.

Similar Private Companies By Industry

Company Name Region
Abba Eye Care, Incorporated United States
El Paso Healthcare System, Ltd. United States
Doctors' Memorial Hospital Inc. United States
UnitedHealthcare of New England, Inc. United States
Global Medical United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mayo Foundation For Medical Education And Research, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at